arrow_back Back to App

Glioblastoma Awareness Day: Supporting Patients and Research

The U.S. Senate designated July 20, 2022, as Glioblastoma Awareness Day. This aims to increase public understanding of this aggressive brain cancer, honor patients, and encourage research into new treatments, potentially improving the quality of life for those affected and their families.
Key points
Designation of July 20 as Glioblastoma Awareness Day to boost public knowledge about the disease.
Support for glioblastoma research, including new therapies and diagnostics, potentially leading to better treatment outcomes.
Honoring individuals affected by glioblastoma and their caregivers, recognizing their vital role in the fight against the disease.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 117_SRES_614
Sponsor: Sen. Graham, Lindsey [R-SC]
Process start date: 2022-05-03
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution designating July 20, 2022, as "Glioblastoma Awareness Day".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_SRES_614.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-05-03.

What are the main provisions?

Key points include:

  • Designation of July 20 as Glioblastoma Awareness Day to boost public knowledge about the disease.
  • Support for glioblastoma research, including new therapies and diagnostics, potentially leading to better treatment outcomes.
  • Honoring individuals affected by glioblastoma and their caregivers, recognizing their vital role in the fight against the disease.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Graham, Lindsey [R-SC].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S2292; text: CR S2282)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health